Kairos Pharma Ltd (KAPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,272 | 3,217 | 0 | 0 | N/A |
| Marketable Securities | 2,859 | 1,515 | 0 | 0 | N/A |
| TOTAL | $4,169 | $4,742 | $0 | $0 | $N/A |
| Non-Current Assets | |||||
| Intangibles | 222 | 262 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,377 | 0 | 0 | 0 | 0 |
| TOTAL | $1,599 | $262 | $N/A | $N/A | $N/A |
| Total Assets | $5,768 | $5,004 | $0 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 992 | 1,530 | 0 | 0 | 0 |
| TOTAL | $992 | $1,672 | $0 | $0 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $992 | $1,672 | $0 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,693 | 12,847 | N/A | N/A | N/A |
| Common Shares | 14 | 13 | 0 | 0 | N/A |
| Retained earnings | -8,815 | -7,835 | 0 | 0 | N/A |
| TOTAL | $4,776 | $3,332 | $0 | $0 | $N/A |
| Total Liabilities And Equity | $5,768 | $5,004 | $0 | $0 | $0 |